Aquirre, J.M., et al., “Reaction of 1,2-diarylethylamides with ethyl polyphosphate(EPP): correlation of the von Braun, Ritter and Bischler-Napieralski reactions”, Chemical Abstracts, 111 (13), Abstract No. 115004, pp. 25-27, (Sep. 25, 1989). |
Badia, D., et al., “Silicon-mediated isoquinoline synthesis: preparation and stereochemical characterization of 4-hydroxy-3-phenylisoquinolines”, Chemical Abstracts, 117 (13), Abstract No. 131034, p. 730, (Sep. 28, 1992). |
Bradsher, C.K., et al., “.alpha-Acyl-o-tolunitriles as intermediates in the preparation of 3-substituted isoquinolines and 1-amino-2-benzopyrylium derivatives”, Chemical Abstracts, 089 (21), Abstract No. 179810, pp. 3817-3820, (1978). |
Chen, A.Y., et al., “A New Mammalian DNA Topoisomerase I Poison Hoechst 33342: Cytoxicity and Drug Resistance in Human Cell Cultures”, Cancer Research, 53 (6), pp. 1332-1337, (Mar. 15, 1993). |
Chen, A.Y., et al., “DNA Minor Groove-Binding Ligands: A Different Class of Mammalian DNA Topoisomerase I Inhibitors”, Proc. Natl. Acad. Sci., USA, 90, pp. 8131-8135, (Sep. 1993). |
Chen, A.Y., et al., “DNA Topoisomerases: Essential Enzymes and Lethal Targets”, Annu. Rev. Pharmacol. Toxicol., 34, pp. 191-218, (1994). |
Cherif, A., et al., “N-(5,5-Diacetoxypent-l-yl)doxorubicin: A New Intensely Potent Doxorubicin Analogue”, J. Med. Chem., 35, pp. 3208-3214, (1992). |
Croisy-Delcey, M., et al., “Synthesis and Carcinogenic Activity of Oxidized Benzacridines: Potential Metabolites of the Strong Carcinogen 7-MEthylbenz(c)acridine and of the Inactive Isomer 12-Methylbenz(a)acridine”, American Chemical Society, 26 (2), pp. 303-306, (1983). |
D'Arpa, P., et al., “Topoisomerase-Targeting Antitumor Drugs”, Biochimica et Biophysica Acta, 989, pp. 163-177, (1989). |
Dominguez, E., et al., “Dehydrogenation reactions of 1-substituted-3-aryltetrahydroisoquin oline derivatives”, Chemical Abstracts, 101 (11), Abstract No. 090742, pp. 525-528, (1984). |
Dorofeenko, G.N., et al., “Synthesis of 3-aryl derivatives of 2-benzopyrylium salts with free.alpha-positions”, Chemical Abstracts, 074 (15), Abstract No. 076295, pp. 1013-1014, (1971). |
Fitzgerald, J.J., et al., “Reaction of benzocyclobutene oxides with nitriles: synthesis of hypecumine and other 3-substituted isoquinolines”, Chemical Abstracts, 122 (7), Abstract No. 081704, p. 1128, (Feb. 13, 1995). |
Fox G.J., et al., “para-Bromination of Aromatic Amines: 4-Bromo-N,N-Dimethyl-3-(Trifluoromethyl)Aniline”, Organic Synthesis, 55, pp. 20-23, (1973). |
Fujii, N., et al., “Induction of Mammalian DNA Topoisomeras I-mediated DNA Cleavage and DNA Winding by Bulgarein”, Journal of Biological Chemistry, 268, pp. 13160-13165, (1993). |
Gallo, R.C., et al., “Studies on the Antitumor Activity, Mechanism of Action, and Cell Cycle Effects of Camptothecin”, Journal of the National Cancer Institute, 46, pp. 789-795, (Apr. 1971). |
Gandhi, K.K., et al., “Regioselective thermal cyclization of 3-substituted arylenaminoimine hydrochlorides, a convenient method for the synthesis of functionalized polycyclic quinoline derivatives”, Heterocycles, 41 (5), pp. 911-920, (1995). |
Garcia, A., et al., “A simple direct approach to 1-substituted 3-arylisoquinolines from deoxybenzoins and nitriles”, Chemical Abstracts, 110 (25), Abstract No. 231407, pp. 6681-6686, (Jun. 19, 1989). |
Gatto, B., et al., “Identification of Topoisomerase I as the Cyctotoxic Target of the Protoberberine Alkaloid Coralyne”, Cancer Research, 56, pp. 2795-2800, (1996). |
Giovanella, B.C., et al., “Complete Growth Inhibition of Human Cancer Xenografts in Nude Mice by Treatment with 20-(S)—Camptothecin”, Cancer Research, 51, pp. 3052-3055, (Jun. 1, 1991). |
Goldman, G.H., et al., “Differential poisoning of humand and aspergilus nidulans DNA topoisomerase I by Bi- and Terbenzimidazoles”, Biochemistry, 36 (21), pp. 6488-6494, (1997). |
Hoan, N., et al., “Syntheses from o-halogenated anisoles and phenetoles”, Chemical Abstracts, 41 (20), Abstract No. 6571bg, 1 p., (1947). |
Iwao, M., et al., “A Regiospecific Synthesis of Carbazones via Consecutive Palladium-Catalyzed Cross-coupling and Aryne-Mediated Cyclization”, Heterocycles, 36, pp. 1483-1488, (1993). |
Janin, Y.L., et al., “Synthesis and Evaluation of New 6-Amino-Substituted Benzo[c]phenanthridine Derivatives”, J. Med. Chem, 36 (23), pp. 3686-3692, (1993). |
Kametani, T., et al., “Studies on the synthesis of heterocyclic compounds. DCXXVII. The formation of 2,3,9,10-tetramethoxybenz[c]acridine by treatment of 6,7-dimethoxy-1-(4,5-dimethoxy-2-nitrophen ethyl)-2methylisoquinoline with triethyl phosphite”, Chemical and Pharmaceutical Bulletin, 23 (9), pp. 2025-2028, (1975). |
Kim, J.S., et al., “Influence of steric factors on topoisomerase I inhibition and cytotoxicity of bisbenzimidazoles related to Hoechst 33342”, Abstract 7—Proceedings of the 3rd Annual Scientific Retreat of the Cancer Institute of New Jersey, Princeton Marrtott Forrestal Village, p. 28, (1995). |
Kim, J.S., et al., “Influence of steric factors on topoisomerase I inhibition and cytotoxicity of bisbenzimidazoles related to Hoechst 33342”, Proceedings of the 86th Annual Meeting of the American Association for Cancer Research, 36, Abstract No. 2689, Toronto, Ontario, Canada, p. 451, (Mar. 1995). |
Kim, J.S., et al., “Quantitative structure-activity relationships on 5-substituted terbenzimidazoles as topoisomerase I poisons and antitumor agents”, Bioorg. Med. Chem., 6 (2), pp. 163-172, (1998). |
Kim, J.S., et al., “Steric factors associated with the topoisomerase I inhibiton and cytotoxicity of substituted bisbenzimidazoles”, Abstract 10-Proceedings of the American Association of Pharmaceutical Scientists Eastern Regional Meeting, p. 27, (1995). |
Kim, J.S., et al., “Structure-activity Relationships of Benzimidazoles and Related Heterocycles as Topoisomerse I Poisons”, Biorganic & Med. Chem., 4, pp. 621-630, (1996). |
Kim J.S., et al., “Substituted 2,5′-Bi-1H-benzimidazoles: Topoisomerase I Inhibition and Cytotoxicity”, J. Med. Chem., 39, pp. 992-998, (1996). |
Kim, J.S., et al., “Terbenzimidazoles: influence of 2″-, 4-, and 5-substituents on cytotoxicity and relative potency as topoisomerase I poisons”, J. Med. Chem., 40, pp. 2818, 2821, (1997). |
Kitamura, T., et al., “Isoquinoline derivatives form the Ritter-type reaction of vinly cations”, Chemical Abstracts, 102 (1), Abstract No. 006157, pp. 1351-1354, (Jan. 7, 1985). |
LaVoie, E.J., et al., “Structure-activity studies related to minor groove-binding ligands which inhibit mammalian DNA topoisomerase I”, Abstract 1—Proceedings of the 85th Annual Meeting of American Association for Cancer Research, San Francisco, CA, p. 2699, (Apr. 1994). |
Makhey, D., et al., “Coralyne and Related Compounds as Mammlian Topoisomerase I and Topoisomerase Ii Poisons”, Bioorg. & Med. Chem. Lett., 4, pp. 781-791, (1996). |
Makhey, D., et al., “Protoberberine Alkaloids and Related Compounds as Dual Inhibitors of Mammalian Topoisomerase I and II”, Med Chem. Res., 5, pp. 1-12, (1994). |
Meegalla, S.K., et al., “Synthesis and Pharmacological Evaluation of Isoindolo[1,2-b]quinazolinone and Isoindolo[2,1-a]benzimidiazole Derivatives Related to the Antitumor Agent Batracylin”, J. Med. Chem., 37, pp. 3434-3439, (1994). |
Memetzidis, G., et al., “Structure-affinity relationships of berbines or 5,6,13,13a-tetrahydro-8H-dibenzo[a,g]quino lizines at.alpha.-adrenoceptors”, Eur. J. Med. Chem., 26, pp. 605-611, (1991). |
Nelson, J.T., et al., “Proton and carbon-13 NMR spectra of fifteen substituted isoquinolines”, Chemical Abstracts, 115 (5), Abstract No. 048721, 1 p., (Aug. 5, 1991). |
Peters, D., et al., “Synthesis of Various 5-Substituted Uracils”, J. Heterocyclic Chem., 27, pp. 2165-2173, (Nov./Dec. 1990). |
Pilch, D.S., et al., “A terbenzimidazole that preferentially binds and conformationally alters structurally distinct DNA duplex domains: a potential mechanism for topoisomerase I poisoning”, Proc. Nat'l. Acad. Sci., USA, 94, pp. 13565-13570, (Dec. 1997). |
Pilch, D.S., et al., “Biophysical Characterization of a Cytotoxic, Topoisomerase I Poison”, Abstract 8—Proceedings of the 3rd Annual Scientific Retreat of the Cancer Institute of New Jersey, Princeton Marriott Forrestal Village, Princeton, NJ, p. 3, (Jun. 1, 1995). |
Pilch, D.S., et al., “Characterizing the DNA binding modes of a topoisomerase I-poisoning terbenzimidazole: evidence for both intercalative and minor groove binding properties”, Drug Design and Discovery, 13, pp. 115-133, (1996). |
Piper, J.R., et al., “Synthesis and Antifolate Activity of 5-Methyl-5,10-dideaza Analogues of Aminopterin and Folic Acid and an Alternative Synthesis of 5,10-Dideazatetrahydrofolic Acid, a Potent Inhibitor of Glycinamide Ribonucleotide Formyltransferase”, J. Med. Chem., 31, pp. 2164-2169, (1988). |
Porai-Koshits, B.A., et al., “Imidazole derivatives Synthesis of some polybenzimidazoles”, J. Gen. Chem. USSR, 23, As related in Chemical Abstracts, 48 (10) (1954), Col. 12740, pp. 873-879, (1953). |
Porai-Koshits, B.A., et al., “Imidazole derivatives. Synthesis of some polybenzimidazoles”, Zhur. Obshchei Khim, 23, As related in Chemical Abstracts, 48 (1954) Col. 4523, pp. 835-841, (1953). |
Quast, U., et al., “Heterocyclic.alpha.-carboinolamines with theisoquinuclidine skeleton. 3. Benzoisoquinuclidines”, Chemical Abstracts, 097 (21), Abstract No. 182180, pp. 1501-1508, (1982). |
Safaryan, G.P., et al., “2-Benzopyrylium salts. 25, Reaction of 2-benzopyrylium salts with some nucleophiles”, Chemical Abstracts, 096 (17), Abstract No. 142656, pp. 1608-1611, (1982). |
Schiess, P., et al., “Thermolytic ring opening of acyloxbenzocyclobutenes: and efficient route to 3-substituted isoquinolines”, Chemical Abstracts, 104 (19), Abstract No. 168332, pp. 3959-3962, (May 12, 1986). |
Shcherbakova, I.V., et al., “2-Benzopyrilium salts.35.Synthesis of the natural alkaloid dehydronorcoralydine and other substituted salts of dibenzo[a,g] quinolizine”, Chemical Abstracts, 112 (19), Abstract No. 179554, pp. 75-80, (May 7, 1990). |
Singh, M.P., et al., “Synthesis and Sequence-Specific DNA Binding of a Topoisomerase Inhibitory Analog of Hoechst 33258 Designed for Altered Base and Sequence Recognition”, Chem. Res. Toxicol., 5, pp. 597-607, (1992). |
Sotomayor, N., et al., “Oxidation reactions of 2′-functionalized 3-aryltetrahydro-and 3,4-dihydroisoquinolines”, Chemical Abstracts, 124 (11), Abstract No. 145854, p. 1227, (Mar. 11, 1996). |
Stermitz, F.R., et al., “Synthesis and Biological Activity of Some Antitumor Benzophenanthridinum Salts”, Journal of Medicinal Chemistry, 18, pp. 708-713, (1975). |
Sun, Q., et al., “Structure activity of novel topoisomerase I inhibitors related to Hoechst 33342”, Abstract 6—Proceedings of the American Association of Pharmaceutical Scientists Eastern Regional Meeting, Hyatt Regency Hotel, New Brunswick, NJ, p. 25, (Jun. 5-6, 1995). |
Sun, Q., et al., “Structure Activity of Topoisomerase I Poisons Related to Hoechst 33342”, Bioorganic & Medicinal Chemistry Letters, 4 (24), pp. 2871-2876, (1994). |
Sun, Q., et al., “Structure-activity studies related to minor groove-binding ligands which inhibit mammalian DNA topoisomerase I”, Cancer Institute of New Jersey's First Annual Scientific Retreat, Abstract 2, Princeton Marriott Forrestal Village, Princeton, NJ, p. 66, (Jun. 7, 1994). |
Sun, Q., et al., “Synthesis and Evaluation of Terbenzimidazoles as Topoisomerase I Inhibitors”, Chemical Abstracts, 123 (15), Abstract No. 198740r, p. 1241, (1995). |
Sun, Q., et al., “Synthesis and pharmacological evaluation of a series of novel DNA topoisomerase I inhibitors as antitumor agents”, Abstract 5—Proceedings of the 3rd Annual Scientific Retreat of the Cancer Institute of New Jersey, Princeton Marriott Forrestal Village, Princeton, NJ, p. 27, (1995). |
Sun, Q., et al., “Synthesis and pharmacological evaluation of a series of novel DNA topoisomerase I inhibitors as antitumor agents”, Proceedings of the 86th Annual Meeting of the American Association for Cancer Research, Toronto, Ontario, Canada, p. 2688, (1995). |
Sun, Q., et al., “Synthesis and Pharmacological Evaluation of a Series of Novel DNA Topoisomerase I Inhibitors as Antitumor Agents”, Scientific Proceedings of the 86th Annual Meeting of the American Association for Cancer Research, Abstract 3, Toronto, Canada, 1 p., (Mar. 18-22, 1995). |
Sun, Q., et al., “Synthesis of Benzimidazo[2,1-a]isoquinolines and 5,6-Dihydrobenzimidazo[2,1-a]isoquinolines”, Syn. Lett., submitted, Paper No. 7, 6 p., (1995). |
Sun, S., et al., “Synthesis and Evaluation of Terbenzimidazoles as Topoisomerase I Inyhibitors”, J. Med. Chem, 38, pp. 3638-3644, (1995). |
Vinogradov, A.E., et al., “Some properties of new DNA specific bisbenzimidazole fluorochromes without a piperazine ring”, Biotechnic & Histochemistry, 38 (5), pp. 265-269, (1993). |
Walterova, D., et al., “Isolation, Chemistry and Biology of Alkaloids from plants of Papaveraceae. Part XCV. Practical application of isotachophoresis in analysis of isoquinoline alkaloids”, Chemical Abstract, 104 (12), pp. 23-36, (1986). |
Wang, L., et al., “Inhibition of Topoisomerase I Function by Coralyne and 5,6-Dihydrocoralyne”, Chem. Res. Toxicol., 9, pp. 75-83, (1996). |
Wang, L., et al., “Inhibition of Topoisomerase I Function by Nitidine and Fagaronine”, Chem. Res. Toxicol., 6, pp. 813-818, (1993). |
Yadagiri, B., et al., “Convenient Routes to Substituted Benzimidazoles and Imidazolo[4,5-b]Pyridines Using Nitrobenzene as Oxidant”, Synthetic Communications, 20 (7), pp. 955-963, (1990). |
Yamamoto, Y., et al., “Reaction of 6H-1, 3-oxazin-6-one with benzyne giving isoquinoline derivatives”, Chemical Abstracts, 118 (7), Abstract No. 059563, 2 p., (Feb. 15, 1993). |
Yamashita, Y., et al., “Induction of Mammalian DNA Topoisomerase I and II Mediated DNA Cleavage by Saintopin, a New Antitumor Agent from Fungus”, Biochemistry, 30, pp. 5838-5845, (1991). |
Yamashita, Y., et al., “Induction of Mammalian DNA Topoisomerase I Mediated DNA Cleavage by Antitumor Indolocarbazole Derivatives”, Biochemistry, 31, pp. 12069-12075, (1992). |